Is Infineon Technologies (XTRA:IFX) Fully Valued On China’s GaN Sales Ban? - simplywall.st

Infineon Technologies (IFX) has drawn renewed attention following China’s Supreme People’s Court upholding an injunction on its Gallium Nitride (GaN) products, ending a prolonged patent dispute with I... Read original →

Infineon’s GaN patent loss in China isn’t just a regional sales ban—it disrupts the entire power electronics stack. Downstream AI infrastructure players like NVIDIA and Broadcom may face redesign pressures for efficiency-critical power delivery. Compliance now demands dual-track supply chains, inflating global operational costs. Competitors such as Navitas and domestic Chinese firms like Innoscience will accelerate market capture, especially in consumer fast-charging. While Infineon’s automotive SiC business offers near-term insulation, its GaN roadmap in Asia is effectively dead. The current 63% valuation premium over fair value reflects speculative AI hype, not sustainable tech leadership. Should export controls on advanced nodes (e.g., 3nm) or EUV tools extend to power semiconductors—a plausible escalation—the stock faces inevitable correction within 12–24 months.